Cedar Fair (NYSE:FUN) reported quarterly sales of $365.99 million which beat the analyst consensus estimate of $345.76 million by 5.85 percent. This is a 4.29 percent increase over sales of $350.94 million the same period last year.
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.
